People with atrial fibrillation (Afib) who took low doses of blood-thinning drugs known as direct oral anticoagulants (DOACs) experienced more bleeding during the first three months of treatment.

A hospital in Pittsburgh has become the latest medical center to join a ground-breaking Apple Watch trial in the US that's helping patients with atrial fibrillation ditch blood-thinning medication.

Researchers say anti-clotting meds won't help prevent cognitive decline The finding applies to patients with the heart rhythm disorder A-fib who are under age 65 While they are often prescribed blood ...

MedStar Heart & Vascular Institute now offers patients with irregular heart rhythm a minimally invasive option to reduce the risk of stroke, as well as enable stopping long-term use of blood thinning ...

Because only about 90 minutes passed between your mother’s initial dose of the anticoagulant and the stroke, it is more likely the cause was a preexisting condition rather than an immediate ...

In the first large trial of its kind, the anti-clotting medication rivaroxaban did not lower the risk of cognitive decline, stroke or transient ischemic attack (TIA) in people younger than age 65 who ...

Atrial fibrillation (AFib) is the most common abnormal heart rhythm found in our community. According to the CDC website, an estimated 12 million people in the United States will have atrial ...

While many people do feel symptoms—a rapid heartbeat, skipping a beat, dizziness, extreme shortness of breath— up to a third ...

During February's "American Heart Month," doctors at Central Maine Medical Center (CMMC) in Lewiston, are raising awareness about two procedures they can now perform to help people with atrial ...

(WASHINGTON, June 6, 2024) – Patients with atrial fibrillation (Afib) who took low doses of blood-thinning medications known as direct oral anticoagulants (DOACs) experienced more bleeding episodes ...